Pharmaceutical Composition Comprising Salbutamol

Patent No. EP4452227 (titled "Pharmaceutical Composition Comprising Salbutamol") was filed by Aptar France on Dec 19, 2022. The application was issued on Nov 26, 2025.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
AWA DENMARKAug 26, 2026-
HGFAug 25, 2026HARRISON GODDARD FOOTE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP4452227

APTAR FRANCE
Application Number
EP22847581A
Filing Date
Dec 19, 2022
Status
Granted And Under Opposition
Oct 24, 2025
Publication Date
Nov 26, 2025